Distribution of High-Risk Human Papillomavirus Types Among Women with Histologically Confirmed CIN2+ Lesions in Cameroon

Authors:

Abstract
Introduction: Human papillomavirus (HPV) types 16 and 18 are responsible for over 70% of cervical cancers worldwide. However, emerging evidence from sub-Saharan Africa suggests that non-HPV16/18 high-risk types may contribute substantially to cervical neoplasia. This study described the distribution of high-risk HPV among histologically confirmed CIN2+ lesions in Cameroon.,Methods: We conducted a descriptive study using secondary data from the Cameroon. Data were collected from women diagnosed with histologically confirmed CIN2+ lesions from 2020 to 2025. Sociodemographic, clinical, pathological, and HPV testing data were analyzed using descriptive statistics. HPV infections were categorized as HPV16, HPV18, or non-HPV16/18 types.,Results: 166 women with CIN2+ lesions were included in the study. Of these, 134 (80.7%) were positive for high-risk HPV and 32(19.3%) were HPV negative. Among the HPV-positives, 68(50.7%) were infected with HPV16 and/or HPV18 and 66(49.3%) with a pool of 12 non-HPV16/18 types. No sociodemographic or clinical characteristics differed significantly between the HPV16/18 and the non-HPV16/18 groups. Overall, HPV16 and HPV18 represented 41.0% of all CIN2+ lesions, whereas the pool of 12 non-HPV16/18 types represented 39.8% and HPV-negative lesions represented 19.3%. The pool of 12 non-HPV16/18 types represented the largest category of lesions across CIN2 (43.8%), CIN3 (51.2%), and ICC/micro-invasive disease (34.6%).,Conclusion: HPV16 and HPV18 were detected in less than half of all cases. The non-HPV16/18 types were substantially detected in CIN2, CIN3, and ICC/micro-invasive disease, underscoring the need for comprehensive HPV genotyping studies and ongoing surveillance to inform cervical cancer prevention strategies in the region.